Omnicell, Inc.

NASDAQ:OMCL

Medical - Healthcare Information Services

Healthcare
$34.66 -1.49%

-$0.58 today

Market cap
$1.59B
Beta
0.96
P/E (TTM)
84.1
EPS (TTM)
$0.45
52W Low $26.85High $55.00

Volume 0.34M

Average 0.57M

OMCL Total Equity

Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.

Omnicell, Inc.NASDAQ: OMCL

Total Equity · Q1 FY2026 · quarter ended Mar 2026

Total equity broadly unchanged from a year ago

Total equity stood at $1.26B at the end of Q1 FY2026, down 0.0% from a year earlier and up 2.0% from the prior quarter. Over 3 fiscal years it compounded at +2.9% a year.

Context

  • Total equity amounted to 62.7% of total assets at the end of Q1 FY2026, up 4.3 pp from a year earlier.
  • Total equity increased in 2 of the last 3 fiscal years.

What to watch

Whether total equity keeps falling in the next quarterly balance sheet after a -0.0% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.26B+2.0% QoQ
Last fiscal yearDec 2025
$1.23B-0.9% YoY
Year agoMar 2025
$1.26B-0.0% since
Total Equity past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-0.0%——
1 year-0.9%——
3-year CAGR+2.9%——
5-year CAGR——
10-year CAGR——

Total Equity history

USD · from the balance sheet

Latest · FY2025
1.23B USD
Year-over-year change
-0.9%
4-year CAGR
+1.8%

Total Equity vs competitors

How OMCL compares with its peers on the latest reported figures

  • OMCL's Mar 2026 total equity of $1.26B is the 2nd highest of the 11 companies compared; the peer median is $457.84M.
  • Its year-over-year change of -0.0% is the 7th highest of 11, against a peer median of +9.1%.
  • Total equity amounts to 62.7% of total assets for OMCL, versus a peer median of 57.1%.
OMCL Competitors Peer median
Total Equity for OMCL and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
TDOCTeladoc Health, Inc.Mar 2026$1.34B -6.4%-15.6%47.6%
OMCLOmnicell, Inc.Mar 2026$1.26B -0.0%+2.9%62.7%
TXG10x Genomics, Inc.Sep 2026$838.04M +6.7%-0.4%78.8%
GDRXGoodRx Holdings, Inc.Mar 2026$621.99M -4.9%-8.9%30.8%
ASTHAstrana Health, Inc.Mar 2026$577.46M +11.5%-0.0%24.5%
UFPTUFP Technologies, Inc.Jun 2026$462.43M +20.0%+21.3%67.8%
PGNYProgyny, Inc.Jun 2026$453.26M -12.0%+11.0%63.3%
PHRPhreesia, Inc.Apr 2026$359.09M +27.3%+5.4%53.9%
SDGRSchrödinger, Inc.Sep 2026$301.83M -6.1%-6.7%49.3%
OMDAOmada HealthMar 2026$234.12M +296.9%+13.9%77.3%
SSIISS Innovations International, Inc.Mar 2026$54.52M +34.4%—60.2%
Peer median (excluding OMCL) $457.84M+9.1%-0.0%57.1%

Competitors are the stored peer set for OMCL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents349.05M330.36M467.97M369.2M196.52M
Short-term Investments10.67M11.49M012.48M0
Net Receivables240.89M299.47M263.89M256.4M216.86M
Inventory119.92M147.55M110.1M88.66M100.91M
Other Current Assets31.01M64.17M51.36M61.48M132.08M
Total Current Assets780.7M881.81M927.57M815.49M680.07M
Property, Plant & Equipment (Net)119.69M132.01M133.59M138.3M144.48M
Goodwill738.9M734.27M735.81M734.73M737.95M
Intangible Assets374.61M323.67M277.83M246.7M170.11M
Long-term Investments18.39M32.92M54.8M52.74M60.74M
Tax Assets15.88M22.33M32.9M57.47M58.34M
Other Non-current Assets94.32M83.74M64.37M75.53M123.04M
Total Non-current Assets1.36B1.33B1.3B1.31B1.29B
Total Assets2.14B2.21B2.23B2.12B1.97B
Account Payables71.51M63.39M45.03M51.78M43.99M
Short-term Debt488.15M00174.32M0
Tax Payables3.77M9.64M2.19M11.44M0
Deferred Revenue152.11M187.21M132.29M201.98M283.48M
Other Current Liabilities71.13M73.46M126.02M60.31M57.17M
Total Current Liabilities876.16M428.45M367.79M595.68M476.61M
Long-term Debt0566.57M569.66M166.4M167.6M
Deferred Tax Liabilities51.71M2.1M1.62M1.11M683K
Deferred Revenue (Non-current)20.19M37.39M58.62M76.12M63.25M
Other Non-current Liabilities7.84M6.72M6.32M7.22M9.97M
Total Non-current Liabilities119.65M652.18M670.13M281.97M266.3M
Total Liabilities995.81M1.08B1.04B877.65M742.91M
Common Stock54K55K56K57K58K
Retained Earnings368.57M390.73M370.36M382.89M384.94M
Accumulated OCI(8.41M)(17.09M)(13.43M)(17.2M)(8.85M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity1.15B1.13B1.19B1.24B1.23B
Total Debt541.01M616.74M614.09M382.55M204.35M
Net Debt191.96M286.38M146.12M13.35M7.83M

Omnicell, Inc.

NASDAQ:OMCL

Intrinsic Alpha fair value

Locked

Current Price

$34.66

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.